These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29632999)

  • 1. MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
    Guo J; Liu Z; Shen C; Li Z; Yan F; Tian J; Xian J
    Eur Radiol; 2018 Sep; 28(9):3872-3881. PubMed ID: 29632999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bag-of-features-based radiomics for differentiation of ocular adnexal lymphoma and idiopathic orbital inflammation from contrast-enhanced MRI.
    Hou Y; Xie X; Chen J; Lv P; Jiang S; He X; Yang L; Zhao F
    Eur Radiol; 2021 Jan; 31(1):24-33. PubMed ID: 32789530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deep learning model combining multimodal radiomics, clinical and imaging features for differentiating ocular adnexal lymphoma from idiopathic orbital inflammation.
    Xie X; Yang L; Zhao F; Wang D; Zhang H; He X; Cao X; Yi H; He X; Hou Y
    Eur Radiol; 2022 Oct; 32(10):6922-6932. PubMed ID: 35674824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-Based Radiomics Nomogram for Preoperative Differentiation Between Ocular Adnexal Lymphoma and Idiopathic Orbital Inflammation.
    Yang L; Zhang H; Xie X; Jiang S; Zhang H; Cao X; Hou Y; He X; Wang J; Zhang T; Zhao F
    J Magn Reson Imaging; 2023 May; 57(5):1594-1604. PubMed ID: 36053805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving diagnostic performance of differentiating ocular adnexal lymphoma and idiopathic orbital inflammation using intravoxel incoherent motion diffusion-weighted MRI.
    Jiang H; Wang S; Li Z; Xie L; Wei W; Ma J; Xian J
    Eur J Radiol; 2020 Sep; 130():109191. PubMed ID: 32745898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing brain inflammation from grade II glioma in population without contrast enhancement: a radiomics analysis based on conventional MRI.
    Han Y; Yang Y; Shi ZS; Zhang AD; Yan LF; Hu YC; Feng LL; Ma J; Wang W; Cui GB
    Eur J Radiol; 2021 Jan; 134():109467. PubMed ID: 33307462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2-Weighted Image-Based Radiomics Signature for Discriminating Between Seminomas and Nonseminoma.
    Zhang P; Feng Z; Cai W; You H; Fan C; Lv W; Min X; Wang L
    Front Oncol; 2019; 9():1330. PubMed ID: 31850216
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.
    Wu J; Liu A; Cui J; Chen A; Song Q; Xie L
    BMC Med Imaging; 2019 Mar; 19(1):23. PubMed ID: 30866850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: Cross-validation of a machine learning method.
    Min X; Li M; Dong D; Feng Z; Zhang P; Ke Z; You H; Han F; Ma H; Tian J; Wang L
    Eur J Radiol; 2019 Jun; 115():16-21. PubMed ID: 31084754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
    Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
    Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
    Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
    Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.
    Xu M; Fang M; Zou J; Yang S; Yu D; Zhong L; Hu C; Zang Y; Dong D; Tian J; Fang X
    Eur J Radiol; 2019 May; 114():38-44. PubMed ID: 31005174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules.
    She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C
    Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
    Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative evaluation of histologic grade in invasive breast cancer with T2W-MRI based radiomics signature].
    Huang Y; Cheng Z; Huang X; Liang C; Liang C; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):285-289. PubMed ID: 30971521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.